Carrier systems for the local delivery of antibiotics in bone infections

Drugs

Volumn 59, Issue 6, 2000, Pages 1223-1232

  Kanellakopoulou, Kyriaki ^a,b   Giamarellos Bourboulis, Evangelos J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SISMANOGLIO HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; APATITE; BONE CEMENT; CEFAZOLIN; CEFMETAZOLE; CIPROFLOXACIN; CLINDAMYCIN; COLLAGEN GENTAMICIN SPONGE; DRUG CARRIER; FIBRIN; FLEROXACIN; FLUCLOXACILLIN; FOSFOMYCIN; GENTAMICIN; GLASS; HABEKACIN; HYDROXYAPATITE; ISEPAMICIN; PEFLOXACIN; POLY(METHYL METHACRYLATE); POLY(METHYL METHACRYLATE) CEMENT BEAD; POLYGLYCOLIDE; POLYLACTIC ACID; POLYLACTIDE; POLYURETHAN; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

CHRONIC OSTEOMYELITIS; DRUG DELIVERY SYSTEM; HUMAN; REVIEW; SPONGE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 0034049001     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059060-00003     Document Type: Review

References (53)

1. 1. Mader JT, Landon GC, Calhoun J. Antimicrobial treatment of osteomyelitis. Clin Orthop 1993 Oct; 295: 87-95
2. 2. Walenkamp GHIM. Chronic osteomyelitis. How I do it. Acta Orthop Scand 1997; 68 (5): 497-506
3. 3. Rushton N. Applications of local antibiotic therapy. Eur J Surg 1997; Suppl. 578: 27-30
4. 4. Rissing JP. Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones. Clin Infect Dis 1997; 25 (12): 1327-33
5. 5. Galanakis N, Giamarellou H, Moussas T, et al. Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up. J Antimicrob Chemother 1997; 39 (2): 241-6
6. 6. Buchholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic cement: current concepts. Clin Orthop 1984 Nov; 190: 96
7. 7. Stemberger A, Grimm H, Bader F, et al. Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg 1997; Suppl. 578: 17-26
8. 8. Rutten HJT, Nijuis PHA. Prevention of wound infection in elective colorectal surgery by local application of a gentamicin-containing collagen sponge. Eur J Surg 1997; Suppl. 578: 31-5
9. 9. Kawanabe K, Okada Y, Matsusue Y, et al. Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. J Bone Joint Surg Br 1998; 80 (3): 527-30
10. 10. Itokazu M, Ohno T, Tanemori T, et al. Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats. J Med Microbiol 1997; 46 (9): 779-83
11. 11. Garvin KL, Miyano JA, Robinson D, et al. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. J Bone Joint Surg 1994: 76A (10): 1500-6
12. 12. Tsourvakas S, Hatzigrigoris P, Tsibinos A, et al. Pharmacokinetic study of fibrin clot-ciprofloxacin complex: an in vitro and in vivo experimental investigation. Arch Orthop Trauma Surg 1995; 114 (5): 295-7
13. 13. Dounis E, Korakis T, Anastassiadis A, et al. Sustained release of fleroxacin in vitro from lactic acid polymer. Bull Hosp Jt Dis 1996; 55(1): 16-9
14. 14. Kanellakopoulou K, Kolia M, Anastassiadis A, et al. Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study. Antimicrob Agents Chemother 1999; 43 (30): 714-6
15. 15. Schierholz, JM, Steinhauser H, Rump AFE, et al. Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomaterials 1997; 18 (12): 839-44
16. 16. Tonetti MS, Cortellini P, Carnevale G, et al. A controlled multicenter study of adjunctive use of tetracycline periodontal fibers in mandibular class II furcations with persistent bleeding. J Clin Periodontol 1998; 25 (9): 728-36
17. 17. Fourmousis I, Tonetti MS, Mombelli A, et al. Evaluation of tetracycline fiber therapy with digital image analysis. J Clin Periodontol 1998; 25 (9): 737-45
18. 18. Flemming TF, Weinacht S, Rüdiger S, et al. Adjunctive controlled topical application of tetracycline HC1 in the treatment of localized persistent or recurrent periodontitis. J Clin Periodontol 1998; 23: 914-21
19. 19. Allababidi S, Shah JC. Kinetics and mechanism of release from glyceryl monostearate-based implants: evaluation of release in a gel simulating in vivo implantation. J Pharm Sci 1998; 87 (6): 738-44
20. 20. Henry SL, Galloway KP. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations. Clin Pharmacokinet 1995; 29 (1): 36-45
21. 21. Greene N, Holtom PD, Warren CA, et al. In vitro elution of tobramycin and vancomycin polymethylmethacrylate beads and spacers from simplex and palacos. Am J Orthop 1998; 27 (3): 201-5
22. 22. Nelson CL, Griffin FM, Harrison BH, et al. In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads. Clin Orthop 1992 Nov; 284: 303-9.
23. 23. Adams K, Couch L, Cierny G, et al. In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop 1992 May; 278: 244-52
24. 24. Kuercle DK, Landon GC, Musher DM, et al, Elution of vancomycin, daptomycin and amikacin from acrylic bone cement. Clin Orthop 1991 Mar; 264: 302-8
25. 25. Mader JT, Calhoun J, Cobos J. In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads. Antimicrob Agents Chemother 1997; 41 (2): 415-8
26. 26. Bunetel L, Segui A, Cormier M, et al. Comparative study of gentamicin release from normal and low viscosity acrylic bone cement. Clin Pharmacokinet 1990; 19 (4): 333-40
27. 27. Brien WW, Salvati EA, Klein R, et al. Antibiotic impregnated bone cement in total hip arthroplasty. An in vivo comparison of the elution properties of tobramycin and vancomycin. Clin Orthop 1993 Nov; 296: 242-8
28. 28. Garvin KL, Evans BG, Salvati EA, et al. Palacos gentamicin for the treatment of deep periprosthetic hip infections. Clin Orthop 1994 Jan; 298: 97-105
29. 29. Hanssen AD, Rand JA, Osmon DR. Treatment of the infected total knee arthroplasty with insertion of another prosthesis. Clin Orthop 1994 Dec; 309: 44-55
30. 30. Whiteside LA. Treatment of infected total knee arthroplasty. Clin Orthop 1994 Feb; 299: 169-72
31. 31. Raut VV, Siney PD, Wroblewski BM. One-stage revision of total hip arthroplasty for deep infection. Long-term followup. Clin Orthop 1995 Dec; 321: 202-7
32. 32. Cho SH, Song HR, Koo KH, et al. Antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis. Bull Hosp Jt Dis 1997; 56 (3): 140-4
33. 33. Josefsson G, Gudmundsson G, Kolmert L, et al. Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. Clin Orthop 1990 Apr; 253: 173-8
34. 34. Izquierdo RJ, Northmore-Ball MD. Long-term results of revision hip arthroplasty. Survival analysis with special reference to the femoral component. J Bone Joint Surg [Br] 1994; 76 (1): 34-9
35. 35. Espehaug B, Engesaeter LB, Vollset SE, et al. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg [Br] 1997; 79 (4): 590-5
36. 36. Duncan CP, Masri BA. The role of antibiotic-loaded cement in the treatment of an infection after a hip replacement. J Bone Joint Surg 1994; 76-A(11): 1742-51
37. 37. Younger ASE, Duncan CP, Masri BA. Treatment of infection associated with segmental bone loss in the proximal part of the femur in two stages with use of an antibiotic-loaded interval prosthesis. J Bone Joint Surg 1998; 80-A (1): 60-9
38. 38. Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone cement: an in vitro study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. J Arthroplasty 1998; 13 (3): 331-8
39. 39. Younger AS, Duncan CP, Masri BA, et al. The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty 1997; 12 (6): 615-23
40. 40. Ozaki T, Yoshitaka T, Kunisada T, et al. Vancomycin-impregnated polymethylmethacrylate beads for methicillin-resistant Staphylococcus aureus (MRSA) infection: report of two cases. J Orthop Sci 1998; 3 (3): 163-8
41. 41. McFadden JA. Vascularized partial first metatarsal transfer for the treatment of phalangeal osteomyelitis. J Reconst Microsurg 1998; 14 (5): 309-12
42. 42. Gracia E, Laclériga A, Monzón M, et al. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms. J Surg Res 1998; 79 (2): 146-53
43. 43. Bayston R, Rodgers J. Production of extra-cellular slime by Staphylococcus epidermidis during stationary phase of growth: its association with adherence to implantable devices. J Clin Pathol 1990; 43 (10): 866-70
44. 44. Kendall RW, Duncan CP, Smith JA, et al. Persistence of bacteria on antibiotic loaded acrylic depots. Clin Orthop 1996 Aug; 329: 273-80
45. 45. von Eiff C, Bettin D, Proctor RA, et al. Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis 1997; 25 (5): 1250-1
46. 46. Wachol-Drewek Z, Pfeiffer M, Scholl E. Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 1996; 17 (17): 1733-8
47. 47. Galandiuk S, Wrightson WR, Young S, et al. Absorbable, delayed-release antibiotic beads reduce surgical wound infection. Am Surg 1997; 63 (9): 831-5
48. 48. Lew DP, Waldvogel FA. Quinolones and osteomyelitis: state-of-the-art. Drugs 1995; 49 Suppl. 2: 101-11
49. 49. Kanellakopoulou K, Tsourvakas S, Korakis T, et al. The release of fleroxacin from acrylic bone cement (PMMA) and lactic acid polymer: a comparative in vitro study [abstract no. 129]. 5th International Symposium on New Quinolones. Singapore, 1994: 169
50. 50. Kanellakopoulou K, Rifiotis C, Papakostas K, et al. Therapy of MRSA experimental osteomyelitis with a lactic acid polymer impregnated with pefloxacin [abstract no. B1]. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1995 Sep 17-20: San Francisco (CA). San Francisco (CA): American Society for Microbiology, 1995: 26
51. 51. Dounis E, Rifiotis C, Kanellakopoulou K, et al. Study of the in vivo pefloxacin release from lactic acid polymer, a biodegradable system of controlled drug release [abstract no. 33]. 14th Annual Meeting of the European Bone and Joint Infection Society; 1995. Copenhagen: The European Bone and Joint Infection Society, 1995: 35-6
52. 52. Giamarellos-Bourboulis EJ, Grecka P, Galani I, et al. Comparative in vitro activity and killing effect of trovafloxacin, DU-6859a, levofloxacin and sparfloxacin against Staphylococcus aureus: focus on methicillin-resistant isolates. Clin Drug Invest 1997,14 (4): 330-6
53. 53. Chan YS, Ueng SWN, Wang CJ, et al. Management of small infected tibial defects with antibiotic-impregnated autogenic cancellous bone grafting. J Trauma 1998; 45 (4): 758-64